Data Foundry

Drug recalls 2017

Neostigmine Methylsulfate Injection Solution 5 mL — Class II drug recall D-1078-2017

Terminated recall by Cantrell Drug Company, reported 2017-08-16, distributed nationwide. Lack of Sterility Assurance.

Recall numberD-1078-2017
Product typeDrug
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmCantrell Drug Company, Little Rock, AR, United States
Recall initiated2017-07-14
Classified2017-08-09
Reported by FDA2017-08-16
Terminated2020-09-16
DistributedNationwide (US)
Quantity120,856 syringes
Reason classessterility
NDC52533-0046-15
Lot numbers10081, 10096, 10112, 10117, 10152, 10159, 10170, 10174, 10193, 10202, 10212, 10242, 10276, 10294, 10320, 10328, 10334, 10342, 10364, 10392, 10420, 10427, 10440, 10463, 10495, 10499, 10512, 10556, 10567, 10583
Expiration dates2017-07-25, 2017-07-27, 2017-07-30, 2017-07-31, 2017-08-03, 2017-08-06, 2017-08-07, 2017-08-08, 2017-08-09, 2017-08-10, 2017-08-13, 2017-08-15, 2017-08-17, 2017-08-20, 2017-08-23, 2017-08-24, 2017-08-28, 2017-08-29, 2017-09-03, 2017-09-06, 2017-09-11, 2017-09-12, 2017-09-14, 2017-09-18, 2017-09-22 and 5 more

Product

Neostigmine Methylsulfate Injection Solution 5 mL, 5 mg/5 mL (1 mg/mL) Single-Dose Syringe, Rx Only, Cantrell Drug Company 7321 Cantrell Rd. Little Rock, AR 72207 877-666-5222, NDC 52533-046-15

Reason for recall

Lack of Sterility Assurance.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1078-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.